Zura Bio Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
For the nine months, net loss was USD 51.89 million. Basic loss per share from continuing operations was USD 2.22.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4.46 USD | -8.61% | -15.05% | -4.50% |
1st Jan change | Capi. | |
---|---|---|
-4.50% | 278M | |
+16.73% | 123B | |
+13.04% | 107B | |
-5.80% | 24.01B | |
+2.15% | 22.59B | |
-10.09% | 18.16B | |
-40.52% | 16.84B | |
-14.00% | 16.23B | |
+1.18% | 13.43B | |
+24.18% | 11.32B |